Misoprostol and Teratogenicity: Reviewing the Evidence
Misoprostol for Early Abortion
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Misoprostol, Abortion, and the Law
Medical Abortion Program Brief
Misoprostol for Incomplete Abortion and Miscarriage
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Annotated Bibliography - Misoprostol for Early Abortion
Misoprostol: A New Addition to Post Abortion Care
Sublingual misoprostol after mifepristone
Abortion in the Middle East and North Africa
Postpartum Hemorrhage Program Brief
Misoprostol for incomplete abortion in Tanzania
Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives
Misoprostol for Prevention of Postpartum Hemorrhage
Reference List - Misoprostol for Incomplete Abortion and Miscarriage
Pregnancy Failure and Miscarriage Program Brief
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Blood Loss After Vaginal Delivery
FAQs on Fatal Infection and Medical Abortion - Technical Version
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Expanding Choice in Abortion Services in Armenia
Misoprostol for Women’s Health
Mifepristone for late first trimester abortion
Misoprostol for PPH prevention in homebirths in Pakistan
Two distinct oral routes of misoprostol in mifepristone medical abortion
Materials Development Activities Brief
Postpartum Hemorrhage: A Challenge for Safe Motherhood
STIs/ HIV/ Infectious Disease Program Brief
Postpartum Hemorrhage: Responding to the Challenge
FAQs on Fatal Infection and Medical Abortion - Summary
Treatment of postpartum hemorrhage with misoprostol
Fever after treatment of postpartum hemorrhage
Policy and Advocacy Activities Brief
Technical Assistance Activities Brief
Misoprostol PPH Treatment Study
Social Science Research Activities Brief
Route of Misoprostol Administration
PPH Misoprostol Adjunct Treatment Study
PPH Prevention Study in Pakistan
Sublingual misoprostol for incomplete abortion
FAQ on Hormonal Contraception and HIV
Training and Education Activities Brief
Misoprostol to treat missed abortion in the first trimester
Can mifepristone medical abortion be simplified?
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Issue Brief on Hormonal Contraception and HIV
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Are two doses of misoprostol after mifepristone for early abortion better than one?
PPH Treatment Study in Pakistan
Use of sequential serum hCG and sonography for medical abortion only when indicated
Outlook Newsletter on Hormonal Contraception and HIV
Integrating medical abortion into safe abortion services in South Africa
Reference List - Misoprostol for Prevention of Postpartum Hemorrhage
Relationship of Hormonal Contraception to HIV
PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context
Clostridium sordellii infection in medical abortion
Misoprostol for incomplete abortion in Mozambique
Misoprostol for incomplete abortion in Burkina Faso
Alternatives to mifepristone for early medical abortion
Methotrexate compared to misoprostol alone for early medical abortion
Treatment of incomplete abortion and miscarriage with misoprostol
Improving Current Therapies and Exploring New Options in Abortifacient Technology
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Prevention of postpartum hemorrhage with misoprostol
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Perspectives on reproductive decision-making amongst HIV-infected individuals
Reproductive intentions among HIV-positive women and men
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Mifepristone medical abortion in Albania
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Supervision for use of mifepristone medical abortion
Regimens of misoprostol with mifepristone for early medical abortion
Abortion and sex determination
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
The supreme court and the partial-birth abortion ban act of 2003
Home administration of misoprostol for early medical abortion in India
Annotated Bibliography - Mifepristone Medical Abortion
Community-based kangaroo mother care to prevent neonatal and infant mortality
Increasing women’s choices in medical abortion in Turkey
Acceptability and feasibility of medical abortion in Nepal
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Non-physician clinicians can safely provide first trimester medical abortion
Comparison of serum markers for thrombophilia and autoimmune disease
Alternatives to Routine Follow-Up for Early Medical Abortion
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
High fever following postpartum administration of sublingual misoprostol
What measured blood loss tells us about postpartum bleeding
Misoprostol for Treatment of Postpartum Hemorrhage
Abortion With Self-Administered Misoprostol: A Guide For Women